全文获取类型
收费全文 | 18056篇 |
免费 | 1259篇 |
国内免费 | 75篇 |
专业分类
耳鼻咽喉 | 144篇 |
儿科学 | 449篇 |
妇产科学 | 223篇 |
基础医学 | 2391篇 |
口腔科学 | 381篇 |
临床医学 | 1926篇 |
内科学 | 3511篇 |
皮肤病学 | 166篇 |
神经病学 | 1716篇 |
特种医学 | 728篇 |
外科学 | 2680篇 |
综合类 | 204篇 |
一般理论 | 34篇 |
预防医学 | 1942篇 |
眼科学 | 319篇 |
药学 | 1302篇 |
中国医学 | 31篇 |
肿瘤学 | 1243篇 |
出版年
2023年 | 154篇 |
2022年 | 248篇 |
2021年 | 536篇 |
2020年 | 315篇 |
2019年 | 440篇 |
2018年 | 509篇 |
2017年 | 395篇 |
2016年 | 431篇 |
2015年 | 517篇 |
2014年 | 648篇 |
2013年 | 910篇 |
2012年 | 1351篇 |
2011年 | 1325篇 |
2010年 | 802篇 |
2009年 | 695篇 |
2008年 | 1160篇 |
2007年 | 1128篇 |
2006年 | 1076篇 |
2005年 | 1093篇 |
2004年 | 993篇 |
2003年 | 903篇 |
2002年 | 767篇 |
2001年 | 278篇 |
2000年 | 213篇 |
1999年 | 216篇 |
1998年 | 163篇 |
1997年 | 127篇 |
1996年 | 111篇 |
1995年 | 92篇 |
1994年 | 76篇 |
1993年 | 71篇 |
1992年 | 141篇 |
1991年 | 106篇 |
1990年 | 105篇 |
1989年 | 99篇 |
1988年 | 91篇 |
1987年 | 91篇 |
1986年 | 64篇 |
1985年 | 77篇 |
1984年 | 71篇 |
1983年 | 45篇 |
1982年 | 54篇 |
1981年 | 50篇 |
1980年 | 44篇 |
1979年 | 52篇 |
1978年 | 49篇 |
1976年 | 35篇 |
1974年 | 37篇 |
1973年 | 40篇 |
1971年 | 38篇 |
排序方式: 共有10000条查询结果,搜索用时 7 毫秒
1.
2.
3.
Thomas Asendorf Robin Henderson Heinz Schmidli Tim Friede 《Statistics in medicine》2019,38(9):1503-1528
In some diseases, such as multiple sclerosis, lesion counts obtained from magnetic resonance imaging (MRI) are used as markers of disease progression. This leads to longitudinal, and typically overdispersed, count data outcomes in clinical trials. Models for such data invariably include a number of nuisance parameters, which can be difficult to specify at the planning stage, leading to considerable uncertainty in sample size specification. Consequently, blinded sample size re-estimation procedures are used, allowing for an adjustment of the sample size within an ongoing trial by estimating relevant nuisance parameters at an interim point, without compromising trial integrity. To date, the methods available for re-estimation have required an assumption that the mean count is time-constant within patients. We propose a new modeling approach that maintains the advantages of established procedures but allows for general underlying and treatment-specific time trends in the mean response. A simulation study is conducted to assess the effectiveness of blinded sample size re-estimation methods over fixed designs. Sample sizes attained through blinded sample size re-estimation procedures are shown to maintain the desired study power without inflating the Type I error rate and the procedure is demonstrated on MRI data from a recent study in multiple sclerosis. 相似文献
4.
5.
Tim Wagner Jarrett Rushmore Antoni Valero-Cabre 《Cortex; a journal devoted to the study of the nervous system and behavior》2009,45(9):1025-137
Transcranial Magnetic Stimulation (TMS) induces electrical currents in the brain to stimulate neural tissue. This article reviews our present understanding of TMS methodology, focusing on its biophysical foundations. We concentrate on how the laws of electromagnetic induction apply to TMS; addressing issues such as the location, area (i.e., focality), depth, and mechanism of TMS. We also present a review of the present limitations and future potential of the technique. 相似文献
6.
7.
Alan Willmore Tim Sladden Lucy Bates Craig B Dalton 《International journal of health geographics》2006,5(1):30-14
Background
To determine patterns of childhood lead exposure in a community living near a lead and zinc smelter in North Lake Macquarie, Australia between 1991 and 2002. 相似文献8.
9.
10.
Duct-associated lymphoid tissue (DALT) of minor salivary glands and mucosal immunity. 总被引:3,自引:0,他引:3 下载免费PDF全文
Minor salivary glands (MSG) play a substantial role in the secretory immunoglobulin A (sIgA)-mediated immunity of the oral cavity. There are two possibilities for the induction of this immunity: (i) an explicitly local antigenic stimulus, or (ii) a remote stimulus as part of the so-called 'common mucosal immune system'. This communication is an attempt to consolidate available evidence in support of both possibilities and to address the former in detail. Although there is strong circumstantial evidence supporting the feasibility of MSG functioning as a part of the common mucosal immune system, direct experimental evidence is yet to emerge. On the other hand, there is increasing structural and physiological evidence in support of MSG serving as a local immunological organ. The purely local response is attributed to the presence of MSG duct-associated lymphoid tissue (DALT), which is comparable to gut- or bronchial-associated lymphoid tissue (GALT or BALT) in origin, tissue organization and function. DALT is accessible to oral antigens by retrograde passage through MSG ducts. Repeated topical antigenic challenging via the oral mucosa may result in the appearance of interacinar plasma cells carrying specific homologous antibodies in MSG. Gut or enteric priming of the same antigen, by passing the oral mucosa by gastric intubation, need not evoke a remote immune response in MSG. Since DALT is more likely to occur in healthy, young growing individuals, who are less likely to undergo bioptic examination of MSG, it has not yet been documented in humans. The physiologically induced DALT is apt to be confused with focal accumulations of lymphoid tissue in pathologically altered MSG, as a consequence of local and some systemic autoimmune diseases. An attempt is made to demarcaate healthy and pathological MSG on the basis of currently available clinical, serological, immunological and genetic evidence. 相似文献